Brussels Airport begins test shipments of innovative medical treatments in new project
Brussels Airport has launched the first test shipments as part of the new Precision Therapy Logistics Gateway (PTLG) project.
In this project, innovative treatments for cancer and rare diseases will be shipped from Brussels Airport to Dallas, United States. The shipments are personalised treatments for individual patients, including cell, gene, and radioligand therapies, which all require fast, reliable transport under strictly controlled conditions, including temperature and lead time. Brussels Airport has already established itself as having extensive expertise in this area, with a total capacity of approximately 45,000m2 of temperature-controlled storage space in the cargo area.
10 test shipments of cell and blood samples have been successfully transported under the trial, with an additional 50 shipments expected in the coming weeks. The partners of the project aim to develop an internationally recognised standardised protocol for the logistics chain of precision therapies: in doing so, patients may no longer need to travel themselves to reach specific treatments, significantly increasing treatment accessibility.
Find out more in Brussels Airport’s press release.
